Toll-like Receptor Signaling-deficient Cells Enhance Antitumor Activity of Cell-based Immunotherapy by Increasing Tumor Homing.

Cancer Res Commun · 2023 · PMC9976589 · PMID 36875156

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Mice transferred with splenocytes from previous OAd-MSC WT and of OAd-MSC TLR4 −/− groups showed a trend toward decreased tumor growth compared to those treated with splenocytes from PBS group ( Supplementary Fig.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.